Moderator
Chief Operating Officer
Elektrofi
Chief Manufacturing and Supply Officer
Sandoz
Vice President, Cell Therapy Development and Operations
AstraZeneca
SVP, Head of Technical Operations
Elektrofi
SVP & Head of Global Biologics Operating Unit
Merck
Production & Operations: What are the key challenges affecting production speed, scalability, and operational efficiency today?
Workforce & Talent: With billions invested in manufacturing, how is the workforce evolving, and what strategies ensure facilities are properly staffed with trained talent?
Technology & Innovation: Which cutting-edge technologies are having the greatest impact on modern pharmaceutical manufacturing?
Regulatory Landscape: What recent regulatory advancements have been made, and how can approvals be further streamlined?
Global Access: How can the industry enhance access to innovative medicines across global markets while balancing speed, quality, and compliance?
Chief Operating Officer
Elektrofi
SVP Global Manufacturing Operations
Bristol Myers Squibb
Senior VP, Global Head of CMC Development
Sanofi
Transitioning from batch to continuous manufacturing
Connecting development to scalable, real-world production
Driving efficiency and sustainability in CMC operations
Senior Vice President, Global Quality
Gilead Sciences
SVP, Americas Supply Operations
AstraZeneca
Project Farma
MasterControl
Scale Ready LLC
These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.
Vice President, Small Molecule Science and Technology
Merck
Johnson & Johnson Innovative Medicine
Senior Director, Quality Strategy & Operations
Alnylam
Vice President, Technical Operations Science & Innovation
AstraZeneca
Executive Director, Product Development & Sustainability Lead
AstraZeneca
Vice President, CMC Regulatory Affairs
AstraZeneca
Sr Director, Advanced Therapies MSAT
Johnson & Johnson
Executive Site Director
Lonza
Sr. Director, DS Network Smart Factory Lead
Moderna
Senior Director, Biotech Production
Regeneron
Associate Vice President, Industrial Franchise Leader, Rare Disease
Sanofi
Approaches to structuring global manufacturing networks for flexibility, resilience, and growth
Balancing internal capacity with external partnerships and regional hubs
Strategies for adapting to changing demand, new modalities, and emerging markets
Lessons in optimizing tech transfer, site readiness, and operational efficiency across multi-site networks
Prioritizing deviations, investigations, and inspections with predictive risk models
Balancing speed to market and regulatory rigor for cell, gene, and novel biologics
Integrating digital tools for real-time oversight and early detection of quality issues
Case studies on managing uncertainty in untested modalities
SVP, Head of Product Development & Clinical Supply
Alexion Pharmaceuticals
Aligning scientific excellence with human impact to drive the next wave of transformative therapies
Honeywell Life Sciences
Boehringer Ingelheim
Boston Institute of Biotechnology, LLC
These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.
Amgen
Chief Operating Officer
Elektrofi
Körber Pharma Software
Chief Technology Officer
Elektrofi
Group Vice President, Global API & Dry Products Manufacturing
Eli Lilly
Exploring how Lilly’s rapid capacity expansion balances growth, reliability, and operational excellence across global manufacturing networks
Identifying advanced technologies, including large-scale single-use systems and digital tools, that drive modernization and efficiency
Highlighting real-world examples of integrating innovation, quality, and compliance to build resilient, future-ready production capabilities
Senior Vice President of Cell Therapy Development and Operations
Bristol Myers Squibb
Global Vice President, Quality, Regulatory and EH&S
Thermo Fisher Scientific
Why many quality agreements fail in practice — and how to make them effective.
Moving beyond compliance to true end-to-end collaboration.
These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.
Fabriq
Looking at the benefits of prioritizing R&D to develop GMP-ready technologies for biologics and cell & gene therapies.
Strategies to adopt advanced, cost-intensive equipment and processes.
Discussing opportunities to improve collaboration, data sharing, and process standardization across the industry.
Driving faster, more cost-efficient development through innovation and strategic investment.
Accenture
Moderator
Chief Technology Officer
Elektrofi
VP, Head of Pharmaceutical Sciences Program Leadership
Takeda
Chief Technology Officer
Elektrofi
Executive Director, Intercompany Operations, (GLS) (GSC) (GPS)
Bristol Myers Squibb
Director, Enterprise Quality Training & Documentation
CSL (Seqirus)
Site Quality Lead
Eli Lilly
Sr. Director, Corporate QA Audit Program and Inspection Management
Gilead
Executive Director, Head of Quality Policy & Advocacy
Gilead
Director, Biotherapeutics Site & External Planning
Johnson & Johnson
Sr Director, Supplier & Vendor Quality
Johnson & Johnson
Sr. Director of DNA Operations & Manufacturing Support
Moderna
VP, Supply Chain
Moderna
Senior Director, Manufacturing Sciences and Technology
Moderna
Sr. Director Manufacturing Operations
Regenxbio
Global Head, CMC Product development and industrialization, mRNA Center of Excellence
Sanofi
SVP, Head of Sustainability and Technology, R&D
Takeda
"*" indicates required fields
